Annexon Inc.

NASDAQ: ANNX
Share price (1/8/25): $4.84
Market cap (1/8/25): $516 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Free writing prospectus

Ownership Filter

Carson William H.

Bain Capital Life Sciences Fund, L.P.

News Filter

Announces Positive Topline Results From Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome

Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

Presents Phase 2 Vision Preservation Data With ANX007 in Dry AMD Patients With Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting

Reports Second Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

Provides Update on ARCHER II Global Registrational Program in Geographic Atrophy

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness